Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 350 participants.

Also called NCT01371058

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 350 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01371058
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01371058. Randomized; no masking; primary purpose prevention. Start 2011-03 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
Acronym
spirit
Intervention (Drug)
high maintenance clopidogrel
Intervention (Drug)
routine dual antiplatelet
Intervention (Drug)
policosanol plus dual antiplatelet
Lead sponsor
Shenyang Northern Hospital (class: other)

Record details

Record id
cardio:ct-nct01371058
Content hash
01d2ae8dff826abfcbd5983a1842fbd9a1a0e66e875aa0fb368f62d376bbb681